Explore how OCD and schizophrenia overlap, complicating diagnosis and care, and learn spectrum-based strategies and treatment pitfalls for managing schizo-obsessive symptoms.
|Articles|August 17, 2022
Connecting With Loved Ones
Author(s)Rif S. El-Mallakh, MD
“Perhaps the most important thing in our lives is really our relationships with the people we care about.”
Advertisement
In this installment of More Than Medicine, Rif El-Mallakh, MD, shares how exchanging cards with friends and family helps him feel connected to the people he cares about most.
Dr El-Mallakh is the director of the Mood Disorders Research Program at the University of Louisville School of Medicine in Louisville, Kentucky.
Dr El-Mallakh also recently spoke about combination therapy in bipolar disorder at the
Advertisement
Related to this article
How estrogen dips during menstruation, pregnancy, postpartum, and menopause can trigger schizophrenia relapse, and what it means for antipsychotic dosing.
Psychiatric Times honors those who served with reflections from a World War I diary and new studies on veteran PTSD and suicide risk.
Cingulate shares plans to resubmit its ADHD candidate CTx-1301 to the FDA, following a CRL tied to CMC information requests
The American Society of Addiction Medicine has released the first clinical guide and national resource for managing the intoxication and withdrawal of medetomidine.
Digital memory tests flag subtle preclinical Alzheimer changes, especially with neocortical tau; scalable tools may boost future trial screening.
How ED physicians and psychiatrists team up to cut mental health boarding, reduce unnecessary tests, and deliver faster, safer ED crisis care.
In the second positive phase 3 trial of lumateperone (Caplyta) for bipolar mania, participants saw improved manic symptoms vs placebo as early as day 3.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Cannabis Use Prevalent In Substance-Related Adolescent Emergency Care: Insights From Kevin Xu, MD
2
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
3
New National Guidance for Managing Medetomidine Intoxication and Withdrawal
4
Lumateperone Shows Significant and Rapid Improvement in Bipolar Mania
5